Related Experiment Video
Updated: Oct 3, 2025
04:16
Author Spotlight: Advancing Lung Transplant Immunology Through Intravital Imaging
Published on: April 19, 2024
1.3K
MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction
Naofumi Miyahara1,2, Alberto Benazzo1, Felicitas Oberndorfer3
1Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Summary
Micro-RNA-21 (miR-21) is elevated in chronic lung allograft dysfunction (CLAD), particularly restrictive allograft syndrome (RAS). This study suggests miR-21 may play a role in CLAD development and could be a therapeutic target.
Area of Science:
- Pulmonology
- Molecular Biology
- Transplantation Immunology
Background:
- Micro-RNA-21 (miR-21) is implicated in epithelial-to-mesenchymal transition (EMT), a process linked to chronic lung allograft dysfunction (CLAD).
- Understanding miR-21's role in CLAD is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression of miR-21 and EMT markers in CLAD lung explants.
- To assess circulating miR-21 levels in CLAD patients compared to stable recipients.
Main Methods:
- Analysis of miR-21, vimentin, Notch intracellular domain (NICD), and SMAD 2/3 expression in explanted lungs from CLAD patients undergoing retransplantation.
- Measurement of serum miR-21 concentrations in CLAD and stable lung transplant recipients.
Main Results:
- Higher miR-21 expression frequency was observed in restrictive allograft syndrome (RAS) compared to bronchiolitis obliterans syndrome (BOS) (86% vs 30%, p=0.01).
- Vimentin, NICD, and p-SMAD 2/3 were frequently detected in BOS and RAS tissues, but negative in controls.
- RAS patients exhibited a significant increase in serum miR-21 over time versus stable recipients (p=0.040).
Conclusions:
- This study is the first to highlight miR-21's association with CLAD.
- miR-21 warrants further investigation for its role in CLAD pathogenesis.
- miR-21 presents a potential therapeutic target for CLAD.
